SCHEMBL279032

SCHEMBL279032

C=C(/N=C/c1cc(Cl)ccc1Oc1ccc(SC)cc1)O[Si](C)(C)C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 8/20 0.45
SLC6A2 P23975 3/20 0.45
SLC6A3 Q01959 3/20 0.45
HTT P42858 1/20 0.36
HPGD P15428 5/20 0.35
TSHR P16473 2/20 0.35
ALDH1A1 P00352 3/20 0.34
MAPT P10636 3/20 0.34
PKM P14618 1/20 0.34
HRH3 Q9Y5N1 1/20 0.32
CYP1A2 P05177 2/20 0.32
CYP1A1 P04798 1/20 0.32
CYP1B1 Q16678 1/20 0.32
MEN1 O00255 3/20 0.32
KMT2A Q03164 3/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
KDM4E B2RXH2 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL279350 0.84 TBXA2R (0.36) SLC6A4SLC6A3HTTHPGDTSHR
SCHEMBL279345 0.84 SLC6A4 (0.38) SLC6A4HTTHPGDTSHRMAPT
SCHEMBL279212 0.82 MEN1 (0.39) HTTHPGDALDH1A1MAPTPKM
SCHEMBL278999 0.82 ALDH1A1 (0.39) ALDH1A1MAPTCYP1A2MEN1KMT2A
SCHEMBL7841968 0.80 KMT2A (0.42) HPGDTSHRALDH1A1MAPTCYP1A2
SCHEMBL279201 0.78 HPGD (0.37) HTTHPGDTSHRALDH1A1MAPT
SCHEMBL279179 0.77 LMNA (0.44) SLC6A4SLC6A2SLC6A3HTTHPGD
SCHEMBL275677 0.77 LMNA (0.44) SLC6A4SLC6A2SLC6A3HTTHPGD
SCHEMBL13929107 0.76 HPGD (0.35) HTTHPGDTSHRALDH1A1MAPT
SCHEMBL278953 0.75 HPGD (0.40) HTTHPGDTSHRALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8134001-B2 Spiroindolinone derivatives HOFFMANN-LA ROCHE INC. (US) 2012-03-13 US disclosed
US-20090156610-A1 Spiroindolinone Derivatives DING QINGJIE 2009-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156610-A1 Spiroindolinone Derivatives SDHA, AR, XPOT SLC6A4 2563/4885SLC6A2 3370/4885SLC6A3 2123/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.